ER
Erasca, Inc.
ERAS · NASDAQ
$15.34 -3.10% (-$0.49)
1M -15.14%
Market Cap $5.33B
P/E Ratio -
Div. Yield -
ROE 80.43%
Bulios Fair Price
$10.08
34.3% downside
Trenutna cena
$15.34
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ERAS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 14.73x
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 7.57%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 37.52%
Asset turnover 0.00x
ROE 80.43%
Debt
100 /100
Low Debt/Equity 0.12x
Current ratio 8.29x
Int. coverage N/A
Stability
74 /100
Stable Beta 0.65x
Profitable years 0
EPS volatility 20.73%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ERAS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jonathan E. Lim
Employees
103
Headquarters
San Diego
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report